D. Tural Et Al. , "Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab," ESMO Virtual Congress , vol.31, ELECTR NETWORK, 2020
Tural, D. Et Al. 2020. Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab. ESMO Virtual Congress , (ELECTR NETWORK).
Tural, D., Olmez, O. F., Sumbul, A. T., Ozhan, N., Akar, E., Cakar, B., ... Kostek, O.(2020). Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab . ESMO Virtual Congress, ELECTR NETWORK
Tural, D. Et Al. "Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab," ESMO Virtual Congress, ELECTR NETWORK, 2020
Tural, D. Et Al. "Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab." ESMO Virtual Congress , ELECTR NETWORK, 2020
Tural, D. Et Al. (2020) . "Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab." ESMO Virtual Congress , ELECTR NETWORK.
@conferencepaper{conferencepaper, author={D. Tural Et Al. }, title={Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab}, congress name={ESMO Virtual Congress}, city={}, country={ELECTR NETWORK}, year={2020}}